Qiagen NV (0RLT)

London


	Symbol		Exchange		Currency
	QIA		Derived		EUR	Real-time
	QIA		Xetra		EUR	Delayed
	QIAd		BATS Europe		EUR	Delayed
	QGEN		NYSE		USD	Real-time
	0RLT		London		EUR	Real-time
	1QGEN		Milan		EUR	Real-time
	QIA		Frankfurt		EUR	Delayed
	QIA		TradeGate		EUR	Delayed
	QIA		Hamburg		EUR	Delayed
	QGE2		Vienna		EUR	Real-time

Currency in EUR

Disclaimer

43.54

0.00(0.00%)

Closed04/10

Fair Value

Day's Range

39.28

43.54

52 wk Range

32.80

48.18

0RLT Income Statement

Featured here, the Income Statement (earnings report) for Qiagen NV, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

1,526.42

1,870.35

2,251.66

2,141.52

1,965.31

Total Revenues Growth

+1.64%

+22.53%

+20.39%

-4.89%

-8.23%

Cost Of Revenues

449.65

574.47

733.72

696.08

667.43

Gross Profit

1,076.77

1,295.88

1,517.94

1,445.44

1,297.89

Gross Profit Growth

+1.65%

+20.35%

+17.14%

-4.78%

-10.21%

Gross Profit Margin %

70.54%

69.29%

67.41%

67.5%

66.04%

Other Operating Expenses, Total

789.04

758.41

860.09

868.82

852.64

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.58%	-3.88%	+13.41%	+1.01%	-1.86%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	157.45	149.07	189.96	189.86	198.51
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	530.11	525.36	584.47	603.95	579.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

287.74

537.47

657.85

576.62

445.25

Operating Income Growth

-5.61%

+86.79%

+22.4%

-12.35%

-22.78%

EBIT Margin %

18.85%

28.74%

29.22%

26.93%

22.66%

Net Interest Expenses

-52.07

-56.89

-44.92

-25.6

25.58

Net Interest Expenses Growth

-12.12%

-9.24%

+21.03%

+43.01%

+199.93%

Interest Expense, Total

-74.19

-71.32

-54.48

-58.36

-53.41

Interest And Investment Income

22.11

14.43

9.56

32.76

78.99

Other Non Operating Expenses, Total

4.83

112.63

8.37

6.74

-1.55

EBT, Excl. Unusual Items

240.49

593.21

621.3

557.76

469.28

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-11.7

-35.44

-27.76

-40.17

-35.31

EBT, Incl. Unusual Items

-77.78

439.47

625.83

512.6

429.81

EBT, Incl. Unusual Items Growth

-134.45%

+665.05%

+42.41%

-18.09%

-16.15%

EBT, Incl. Unusual Items Margin

-5.1

23.5

27.79

23.94

21.87

Income Tax Expense

-36.32

80.28

113.23

89.39

88.51

Net Income to Company

-41.46

359.19

512.6

423.21

341.3

Minority Interest

-

-

-

-

-

Net Income

-41.46

359.19

512.6

423.21

341.3

Net Income Growth

-121.77%

+966.45%

+42.71%

-17.44%

-19.35%

Net Income Margin %

-2.72%

19.2%

22.77%

19.76%

17.37%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-41.46

359.19

512.6

423.21

341.3

Basic EPS - Continuing Operations

-0.19

1.62

2.32

1.92

1.54

Basic EPS - Continuing Operations Growth

-121.76%

+960.2%

+42.99%

-17.29%

-19.56%

Diluted EPS - Continuing Operations

-0.19

1.58

2.28

1.9

1.53

Diluted EPS - Continuing Operations Growth

-122.29%

+936.97%

+44.45%

-16.74%

-19.56%

Basic Weighted Average Shares Outstanding

219.97

221.57

221.14

220.75

221.3

Diluted Weighted Average Shares Outstanding

219.97

227.19

225.07

223.23

223.7

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

500.89

735.08

863.58

774.22

638.88

EBITDA Growth

+1.38%

+46.75%

+17.48%

-10.35%

-17.48%

EBITDA Margin %